21 results
-
List item
Human medicine European public assessment report (EPAR): Cinacalcet Accordpharma (updated)
cinacalcet hydrochloride, Hyperparathyroidism
Date of authorisation: 03/04/2020,
, Revision: 3, Authorised, Last updated: 16/05/2023
Cinacalcet Accordpharma Endocrine System Diseases Parathyroid … cinacalcet Overview Cinacalcet Accordpharma is a medicine used to treat … no other cause. Cinacalcet Accordpharma contains the The substance … -
List item
Human medicine European public assessment report (EPAR): Dasatinib Accordpharma
dasatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 24/03/2022,, Revision: 1, Withdrawn, Last updated: 30/03/2023
Dasatinib Accordpharma Leukemia, Lymphoid Leukemia Neoplasms Lymphoproliferative … Dasatinib Accordpharma … Public statement Dasatinib Accordpharma (dasatinib) Withdrawal of … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 January 2020
CHMP, Last updated: 31/01/2020Cinacalcet Accordpharma … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022
CHMP, Last updated: 05/07/2022Dasatinib Accordpharma … -
List item
Human medicine European public assessment report (EPAR): Dasatinib Accord
dasatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 24/03/2022,, Revision: 1, Withdrawn, Last updated: 30/03/2023
-
List item
National expert: Emilia Cercenado Mansilla, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 41.48 KB | PDF
- Curriculum Vitae - 468.19 KB | PDF
-
List item
Public data from Article 57 database
Last updated: 17/10/2022 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 24/01/2022 to 27/01/2022, Last updated: 16/03/2022 -
List item
Newsletters (updated)
Last updated: 30/05/2023 -
List item
Management Board meeting: 16 March 2023
European Medicines Agency, Amsterdam, the Netherlands, 16/03/2023, Last updated: 04/04/2023 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 06/06/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 February 2022
European Medicines Agency, Amsterdam, the Netherlands, from 21/02/2022 to 24/02/2022, Last updated: 06/04/2021 -
List item
News: Human medicines: highlights of 2022
Last updated: 16/02/2023Accord Haematology/ Haemostaseology Cevenfacta Dasatinib Accord Dasatinib Accordpharma Hemgenix Roctavian Stimufend Dimethyl … -
List item
News: Human medicines: highlights of 2020
Last updated: 21/01/2021APPROVAL Endocrinology Cinacalcet Accordpharma Givlaari Insulin aspart Sanofi Kixelle Lyumjev … -
List item
Annual reports and work programmes (updated)
Last updated: 15/05/2023 -
List item
EMA event supporting materials
Last updated: 14/06/2022 -
List item
News: Annual report 2020 published
Last updated: 14/06/2021 -
List item
News: EMA annual report 2022 published (new)
Last updated: 15/05/2023 -
List item
Leaflets
Last updated: 23/09/2016 -
List item
Guidance documents
Last updated: 19/07/2022